Journals / Organic Communications / 2021 / Cilt: 14 - Sayı: 2

Discovery of new capsaicin and dihydrocapsaicin derivatives as histone deacetylase inhibitors and molecular docking studies

Pages
133–143
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Those data show a new method for providing the isoform-selective histone deacetylase inhibitors from common natural products.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Capsaicin and dihydrocapsaicin were modified at phenolic moieties and allylic of double-bond to provide seven capsaicin and dihydrocapsaicin derivatives.
📊
Key Findings & Data:Their structures were assigned by spectroscopic techniques (1D-NMR and MS).
💡
Conclusion & Impact:Those data show a new method for providing the isoform-selective histone deacetylase inhibitors from common natural products.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Capsaicin and dihydrocapsaicin were modified at phenolic moieties and allylic of double-bond to provide seven capsaicin and dihydrocapsaicin derivatives. Their structures were assigned by spectroscopic techniques (1D-NMR and MS). All compounds were evaluated as histone deacetylase inhibitors via in vitro fluorometric assay at 100 μM. The results revealed that the chloranil derivatives were found to be best histone deacetylase inhibitors among the tested compounds with 86% and 87% inhibitions. In addition, molecular docking experiments of the active compounds with representatives of class I (HDAC1, HDAC2, HDAC3 and HDAC8), class IIa (HDAC4 and HDAC7) and class IIb (HDAC6) HDAC isoforms displayed potential isoform-selective HDAC inhibitors. Those data show a new method for providing the isoform-selective histone deacetylase inhibitors from common natural products.

🔖

Cite This Article

KUMBOONMA, P., SAENGLEE, S., SENAWONG, T., PHAOSİRİ, C. (2021). Discovery of new capsaicin and dihydrocapsaicin derivatives as histone deacetylase inhibitors and molecular docking studies. Organic Communications, Cilt: 14 - Sayı: 2, 133–143. https://ajindex.com/articles/340689

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Paris, M.; Porcelloni, M.; Binaschi, M.; Fattori, D. Histone deacetylase inhibitors: from bench to clinic. J. Med. Chem. 2008, 51, 1505-1529
  2. Noh, H.; Oh, E. Y.; Seo, J. Y.; Yu, M. R.; Kim, Y. O.; Ha, H.; Lee, H. B. Histone deacetylase-2 is a key regulator of diabetes and transforming growth factor-β1-induced renal injury. Am. J. Physiol. Renal. Physiol. 2009, 207, 729-739
  3. Bertrand, P. Inside HDAC with HDAC inhibitors. Eur. J. Med. Chem. 2010, 45, 2095-2116
  4. Manal, M.; Chandrasekar, M. J.; Gomathi Priya, J.; Nanjan, M. J. Inhibitors of histone deacetylase as antitumor agents: A critical review. Bioorg. Chem. 2016, 67, 18-42
  5. Micelli, C.; Rastelli, G. Histone deacetylases: structural determinants of inhibitor selectivity. Drug Discov. Today 2015, 20, 718-735
  6. Bartling, B.; Hofmann, H. S.; Boettger, T., Hansen, G.; Burdach, S.; Silber, R. E.; Simm, A. Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer 2005, 49, 145-154
  7. Khabele, D.; Son, D. S.; Parl, A. K.; Goldberg, G. L.; Augenlicht, L. H.; Mariadason, J. M.; Rice, V. M. Drug-induced inactivation or gene silencing of class I histone deacetylase suppresses ovarian cancer cell growth: Implication for therapy. Cancer Biol. Ther. 2007, 6, 795-801
  8. Oehme, I.; Deubzer, H. E.; Wegener, D.; Pickert, D.; Linke, J. P.; Hero, B.; Kopp-Schneider, A.; Westermann, F.; Ulrich, S. M.; von Deimling, A.; Fisher, M.; Witt, O. Histone deacetylase 8 in neuroblastoma tumorigenesis. Clin. Cancer Res. 2009, 15, 91-99
  9. Rettig, I.; Koeneke, E.; Trippel, F.; Mueller, W. C.; Burhenne, J.; Kopp-Schneider, A.; Fabian, J.; Schober, A.; Fernekorn, U.; von Deimling, A.; Deubzer, H. E.; Milde, T.; Witt, O.; Oehme, I. Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acidmediated differentiation. Cell Death. Dis. 2015, 6, e1657
  10. Guan, J. S.; Haggarty, S. J.; Giacometti, E.; Dannenberg, J. H.; Joseph, N.; Gao, J.; Nieland, T. J.; Zhou, Y.; Wang, X.; Mazitschek, R.; Bradner, J. E.; De Pinho, R. A.; Jaenisch, R.; Tsai, L. H. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009, 459, 55-60
  11. Song, J.; Noh, J. H.; Lee, J. H.; Eun, J. W.; Ahn, Y. M.; Kim, S. Y.; Lee, S. H.; Park, S. W.; Yoo, N. J.; Lee, J. Y.; Nam, S.W. Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS 2005, 113, 264-268
  12. Damaskos, C.; Kar